Genetic and epigenetic alterations in tumor progression in a dedifferentiated chondrosarcoma

Pathology Research and Practice

Volumn 199, Issue 6, 2003, Pages 437-444

  Röpke, Martin ^a   Boltze, C ^a   Neumann, H W ^a   Roessner, A ^a   Schneider Stock, R ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Dedifferentiated chondrosarcoma; DNA methylation; Microdissection; p53 mutation; p53 LOH; Rb LOH

Indexed keywords

DEATH ASSOCIATED PROTEIN KINASE; DNA; PROTEIN KINASE; PROTEIN P14; PROTEIN P16; PROTEIN P21; PROTEIN P73; REGULATOR PROTEIN; RETINOBLASTOMA PROTEIN; UNCLASSIFIED DRUG; UVOMORULIN;

ADULT; ANAPLASTIC CARCINOMA; APOPTOSIS; ARTICLE; CANCER GENETICS; CANCER GRADING; CANCER GROWTH; CARTILAGE CELL; CASE REPORT; CELL ADHESION; CELL CYCLE; CHONDROSARCOMA; CPG ISLAND; DISSECTION; DNA METHYLATION; DNA REPAIR; FEMALE; GENE MUTATION; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; OSTEOSARCOMA; PROMOTER REGION; TUMOR DIFFERENTIATION; TUMOR SUPPRESSOR GENE;

EID: 0043065484     PISSN: 03440338     EISSN: None     Source Type: Journal    
DOI: 10.1078/0344-0338-00443     Document Type: Article

References (38)

1. Aigner T, Unni KK (1999) Is dedifferentiated chondrosarcoma a de-differentiated chondrosarcoma? J Pathol 189: 445-447
2. Aigner T (2002) Towards a new understanding and classification of chondrogenic neoplasias of the skeleton - biochemistry and cell biology of chondrosarcoma and its variants. Virchows Arch 441: 219-230
3. ARF do not play a primary role in human chondrosarcoma, tissues. Int J Cancer 93: 703-705
4. Asp J, Sangiorgi L, Inerot SE, Lindahl A, Magagnoli G, Benassi MS, Picci P (2000) Changes of the p16 gene but not the p53 gene in human chondrosarcoma tissues. Int J Cancer 85: 782-786
5. Benassi MS, Molendini L, Gamberi G, Magagnoli G, Ragazzini P, Gobbi GA, Sangiorgi L, Pazzaglia L, Asp J, Brantsing C, Picci P (2001) Involvment of INK4A gene products in the pathogenesis and development of human osteosarcoma. Cancer 92: 3062-3067
6. Bovée JVMG, Cleton-Jansen AM, Rosenberg C, Taminimau AHM, Cornelisse CJ, Hogendoorn PCW (1999) Molecular genetic characterization of both componenets of a dedifferentiated chondrosarcoma, with implications for its histogenesis. J Pathol 189: 454-462
7. Budowle B, Chakraborty R, Giusti AM, Eisenberg AJ, Allen RC (1991) Analysis of the VNTR locus D1S80 by the PCR followed by high-resolution PAGE. Am J Hum Genet Jan 48: 137-144
8. Campanacci M (1990) Bone and soft tissue tumors. Springer-Verlag: Wien - New York: 285
9. Cohen O, Feinstein E, Kimchi A (1997) DAP-kinase is a Ca2+/calmodulin-dependent, cytoskeletal-associated protein kinase, with cell death-inducing functions that depend on its catalytic activity EMBO J 16: 998-1008
10. Dumon KR, Ishii H, Vecchione A, Trapasso F, Baldassarre G, Chakrani F, Druck T, Rosato EF, Williams NN, Baffa R, During MJ, Huebner K (2001) Fragile histidine triad expression delays tumor development and induces apoptosis in human pancreatic cancer. Cancer Res 61: 4827-4836
11. Esteller M (2002) CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future. Oncogene 21: 5427-5440
12. Esteller M, Fraga MF, Guo M, Garcia-Foncillas J, Hedenfalk I, Godwin AK, Trojan J, Vaurs-Barriere C, Bignon YJ, Ramus S, Benitez J, Caldes T, Akiyama Y, Yuasa Y, Launonen V, Canal MJ, Rodriguez R, Capella G, Peinado MA, Borg A, Aaltonen LA, Ponder BA, Baylin SB, Herman JG (2001) DNA methylation patterns in hereditary human cancers mimic sporadic tumorigenesis. Human Molecular Genetics 26: 3001-3007
13. Frassica FJ, Unni KK, Beabout JW, Sim FH (1986) Dedifferentiated chondrosarcoma. A report of the clinicopathological features and treatment of seventy-eight cases. J Bone Joint Surg [A] 68: 1197-1205
14. Giarnieri E, Mancini R, Pisani T, Alderisio M, Vecchione A (2000) Msh2, Mlh1, Fhit, p53, Bcl-2, and Bax Expression in Invasive and in Situ Squamous Cell Carcinoma of the Uterine Cervix. Clin Cancer Research 6: 3600-3606
15. Grothe HJ, Schneider-Stock R, Neumann, W, Roessner A (2000) Mutation of p53 with loss of heterozygosity in the osteosarcomatous component of a dedifferentiated chondrosarcoma. Virchows Arch 436: 494-497
16. Goldmann D, Merril CR (1982) Silver staining of DNA in polyacrylamide gels: linearity and effect of fragment size. Electrophoresis 3: 24-26
17. Hinohara S, Satake N, Sekine K, Kaneko Y (1998) Abnormalities of the FHIT transcripts in osteosarcoma and Ewing sarcoma. Jpn J Cancer Res 89: 887-894
18. Ichimiya S, Nakagawara A, Sakuma Y, Kimura S, Ikeda T, Satoh M, Takahashi N, Sato N, Mori M (2000) p73: Structure and function. Pathology International 50: 589-593
19. Ishii H, Dumon KR, Vecchione A, Trapasso F, Mimori K, Alder H, Mori M, Sozzi G, Baffa R, Huebner K, Croce CM (2001) Effect of adenoviral transduction of the fragile histidine triad gene into esophageal cancer cells. Cancer Res 61: 1578-1584
20. Jin Y, Blue EK, Dixon S, Hou L, Wysolmerski RB, Gallagher PJ (2001) Identification of a New Form of Death-associated Protein Kinase that Promotes Cell Survival. J Biol Chem 276: 39667-39678
21. Jost CA, Marin MC, Kaelin WG Jr. (1997) p73 is a human p53-related protein that can induce apoptosis. Nature 389: 191-194
22. Kawano S, Miller CW, Gombart AF, Bartram CR, Matsuo Y, Sakashita A, Said J, Tatsumi E, Koeffler HP (1999) Loss of p73 gene expression in leukemia/lymphomas due to hypermethylation. Blood 94: 1113-1120
23. Mori K, Chano T, Kushima R, Hukuda S, Okabe H (2002) Expression of E-cadherin in chordomas: diagnostic marker and possible role of tumor cell affinity. Virchows Arch 440: 123-127
24. Nakagawa S, Yoshikawa H, Kimura M, Kawana K, Matsumoto K, Onda T, Kino N, Yamada M, Yasugi T, Taketani Y (1999) A possible involvement of aberrant expression of the FHIT gene in the carcinogenesis of squamous cell carcinoma of the uterine cervix. Br J Cancer 79:589-594
25. Oue N, Sentani K, Yokozaki H, Kitadai Y, Ito R, Yasui W (2001) Methylation status of the DNA repair genes hMLH1 and MGMT in gastric carcinoma and metaplastic mucosa. Pathobiology 69: 143-149
26. Pekarsky Y, Zanesi N, Palamarchuk A, Huebner K, Croce CM (2002) FHIT: from gene discovery to cancer treatment and prevention. The Lancet Oncology 3: 748-754
27. Pomerantz J, Schreiber-Agus N, Liegeois NJ, Silverman A, Alland L, Chin L, Potes J, Chen K, Orlow I, Lee HW, Cordon-Cardo C, DePinho RA (1998) The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53. Cell 92: 713-723
28. Prives C, Hall PA (1999) The p53 pathway. J Pathology 187: 112-126
29. Sanerkin NG, Woods CG (1979) Fibrosarcomata and malignant fibrous histiocytoma arising in relation to enchondromata. J Bone Jt Surg; 61B: 366-372
30. Sard L, Accornero P, Tornielli S, Delia D, Bunone G, Campiglio M, Colombo MP, Gramegna M, Croce CM, Pierotti MA, Sozzi G (1999) The tumor-suppressor gene FHIT is involved in the regulation of apoptosis and in cell cycle control. Proc Natl Acad Sci USA 96: 8489-8492
31. Schneider-Stock R, Boltze C, Lasota J, Miettinen M, Peters B, Pross M, Roessner A, Gunther T (2003) High Prognostic Value of p16INK4 Alterations in Gastrointestinal Stromal Tumors. J Clin Oncol 21: 1688-1697
32. Sevignani C, Calin GA, Cesari R, Sarti M, Ishii H, Yendamuri S, Vecchione A, Trapasso F, Croce CM (2003) Restoration of Fragile Histidine Triad (FHIT) Expression Induces Apoptosis and Suppresses Tumorigenicity in Breast Cancer Cell Lines. Cancer Research 63: 1183-1187
33. Sherr CJ (1996) Cancer cell cycles. Science 27: 1672-1677
34. Sozzi G, Pastorino U, Moiraghi L, Tagliabue E, Pezzella F, Ghirelli C, Tornielli S, Sard L, Huebner K, Pierotti MA, Croce CM, Pilotti S (1998) Loss of MIT function in lung cancer and preinvasive bronchial lesions. Cancer Res 58: 5032-5037
35. Terek RM, Healey JH, Garin-Chesa P, Mak S, Huvos A, Albino AP (1998) p53 mutations in chondrosarcoma. Diagn Mol Pathol Feb 7 (1): 51-56
36. Walter H, Schneider-Stock R, Mellin W, Gunther T, Nebelung W, Roessner A. (1995) Synchronous multifocal. bone sarcomas - a case report and molecular pathologic investigation. Gen Diagn Pathol 141: 67-74
37. Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach D (1993) p21 is a universal inhibitor of cycle kinases. Nature 366: 701-704
38. Yamaguchi T, Toguchida J, Wadayama B, Kanoe H, Nakayama T, Ishizaki K, Ikenaga M, Kotoura Y, Sasaki MS (1996) Loss of heterozygosity and tumor suppressor gene mutations in chondrosarcomas. Anticancer Res 16: 2009-2015